These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1333201)

  • 1. Woodfruticosin (woodfordin C), a new inhibitor of DNA topoisomerase II. Experimental antitumor activity.
    Kuramochi-Motegi A; Kuramochi H; Kobayashi F; Ekimoto H; Takahashi K; Kadota S; Takamori Y; Kikuchi T
    Biochem Pharmacol; 1992 Nov; 44(10):1961-5. PubMed ID: 1333201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constituents of the leaves of Woodfordia fruticosa Kurz. I. Isolation, structure, and proton and carbon-13 nuclear magnetic resonance signal assignments of woodfruticosin (woodfordin C), an inhibitor of deoxyribonucleic acid topoisomerase II.
    Kadota S; Takamori Y; Nyein KN; Kikuchi T; Tanaka K; Ekimoto H
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2687-97. PubMed ID: 1963810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Woodfordin C, a macro-ring hydrolyzable tannin dimer with antitumor activity, and accompanying dimers from Woodfordia fruticosa flowers.
    Yoshida T; Chou T; Nitta A; Miyamoto K; Koshiura R; Okuda T
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1211-7. PubMed ID: 2393947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Woodfordin D and oenothein A, trimeric hydrolyzable tannins of macro-ring structure with antitumor activity.
    Yoshida T; Chou T; Matsuda M; Yasuhara T; Yazaki K; Hatano T; Nitta A; Okuda T
    Chem Pharm Bull (Tokyo); 1991 May; 39(5):1157-62. PubMed ID: 1913994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of four macrocyclic ellagitannins from Cuphea hyssopifolia.
    Wang CC; Chen LG; Yang LL
    Cancer Lett; 1999 Jun; 140(1-2):195-200. PubMed ID: 10403559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
    Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
    Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camelliin B and nobotanin I, macrocyclic ellagitannin dimers and related dimers, and their antitumor activity.
    Yoshida T; Chou T; Haba K; Okano Y; Shingu T; Miyamoto K; Koshiura R; Okuda T
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3174-6. PubMed ID: 2632067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha.
    Kuriyama M; Tsutsui K; Tsutsui K; Ono Y; Tamiya T; Matsumoto K; Furuta T; Ohmoto T
    Neurol Med Chir (Tokyo); 1997 Sep; 37(9):655-61; discussion 661-2. PubMed ID: 9330528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II.
    Aoyagi Y; Kobunai T; Utsugi T; Oh-hara T; Yamada Y
    Jpn J Cancer Res; 1999 May; 90(5):578-87. PubMed ID: 10391099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tannins as potent inhibitors of DNA topoisomerase II in vitro.
    Kashiwada Y; Nonaka G; Nishioka I; Lee KJ; Bori I; Fukushima Y; Bastow KF; Lee KH
    J Pharm Sci; 1993 May; 82(5):487-92. PubMed ID: 8395599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP; Brown GA; Goldenberg GJ
    Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways.
    Saleh EM; El-awady RA; Eissa NA; Abdel-Rahman WM
    Cancer Biol Ther; 2012 Sep; 13(11):1058-71. PubMed ID: 22895066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
    Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
    Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor.
    Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J
    Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
    Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between DNA topoisomerase II alpha expression and sensitivity to etoposide in human glioma cell lines].
    Hao YJ; Natsume A; Mizuno M; Taniguchi K; Wakabayashi T; Yoshida J
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1403-9. PubMed ID: 10969596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.